Screener
Gilead Sciences GILD Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
| (in millions, except per share amounts) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $674 | $715 |
| Accrued rebates | 4,233 | 4,337 |
| Current portion of long-term debt, net | 2,414 | 2,807 |
| Other current liabilities | 3,699 | 3,953 |
| Total current liabilities | 11,020 | 11,813 |
| Long-term debt, net | 23,832 | 22,129 |
| Long-term income taxes payable | 943 | 896 |
| Deferred tax liabilities | 333 | 402 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Gilead Sciences's accrued expenses?
- Gilead Sciences (GILD) reported accrued expenses of $3.7B in Q2 2026.
- How has Gilead Sciences's accrued expenses changed year-over-year?
- Gilead Sciences's accrued expenses increased by 3.2% year-over-year, from $3.59B to $3.7B.
- What is the long-term trend for Gilead Sciences's accrued expenses?
- Over 5 years (2020 to 2025), Gilead Sciences's accrued expenses has grown at a 11.6% compound annual growth rate (CAGR), from $2.29B to $3.95B.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Gilead Sciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude